摘要:
The invention relates to isoxazolo-pyridazine compounds, in particular those of formula I as described above and to a pharmaceutically acceptable salts thereof, having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, pharmaceutical compositions containing them and their use as cognitive enhancers or for the treatment of cognitive disorders like Alzheimer's disease.
摘要:
A method is provided for augmenting a set of image recordings in which, in addition to making image recordings (95), location data (175) is recorded for locations for which the user desires an, or a further, image recording. This desired-image-recording location data is subsequently used to retrieve one or more corresponding image recordings from a service system (40).
摘要:
A sealing system for an axial flow rotary valve internal combustion engine comprising an array of floating gas seals and an optional oil sealing system. The array of floating seals surrounding a window (15) in the bore (11) of the cylinder head (10) through which the ports (2, 3) of the valve (1) communicate with a combustion chamber (31). The array of floating seals comprising axial seals (16) and circumferential seals (17) housed in slots (18, 19) in the bore of the cylinder head wherein the circumferential seals are disposed axially between the ends of the axial seals.
摘要:
The present invention is concerned with aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives of formula I wherein R1, R2, R3, R4, and R5 are as defined in the specification and claims and with their pharmaceutically acceptable acid addition salts. The invention also relates to methods for preparing such compounds. This class of compounds has a high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease. Thus, the invention also is concerned with pharmaceutical compositions containing compounds of formula I or their pharmaceutically acceptable acid addition salts and methods for the treatment of GABA A α5 mediated diseases, including Alzheimer's disease.
摘要:
The present invention is concerned with aryl-isoxazole-4-carbonyl-pyrrole-2-carboxylic acid amide derivatives of formula wherein R1, R2, R3, R4, and R5, and m are as defined herein and with their pharmaceutically acceptable acid addition salts. This class of compounds have high affinity and selectivity for GABA A α5 receptor binding sites and therefore may be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
摘要:
A local entity without its own means of voice communication is provided with the semblance of having a voice interaction capability. This is done by providing a beacon device at or near the entity, the beacon device transmitting, over a short-range communication link, contact data identifying a voice service associated with, but hosted separately from, the entity. The transmitted contact data is picked up by equipment carried by a nearby person and used to contact the voice service over a wireless network. The person then interacts with the voice service, the latter acting as a voice proxy for the local entity. The contact data can be presented to the user in other ways, for example, by being inscribed on the local entity for scanning or user input into the equipment.
摘要:
Accordingly, there is provided, a method of connecting users of a telecommunications system, the method comprising, receiving a call, playing a prompt in response to the call, receiving voice data, processing voice data to extract keyword information from the voice data, determining signaling information from the keyword data, and connecting the call based on the signaling information.
摘要:
Compounds of the formula (I): wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
摘要:
Compounds of the formula (I) wherein R1, R2, R3, R4, R5, R6 and p are as defined within and a pharmaceutically acceptable salts and (in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
摘要:
A program controller is arranged to automatically authorize or configure or upgrade a program for a customer replaceable card of a system, the controller being arranged to manage the program automatically, according to a licence agreement, and according to a stored history of use of the hardware module. A supplier can track customer changes and enforce more easily different conditions for authorising the program on, different modules from different sources, having different levels of capability. There can be less interaction with the supplier to get specific authorizations. The history can be stored on the module. It can be used to ease inventory tracking and generate billing information.